Search results
13 sie 2020 · Cancer-associated anemia is caused by 1 or more of 3 primary mechanisms: (1) ineffective erythropoiesis, 4,27 (2) hemolysis, or (3) blood loss. 28 Our approach subclassifies potential causes of cancer-associated anemia by first listing 3 broad categories: production, destruction, and loss (bleeding).
red blood cell transfusions are rapid increase of hemoglobin concentration and effectiveness independent of the cause of anemia. However, several adverse reactions may occur after blood component transfusion.
For example, the presence of immunoglobulin G or complement component 3d on the surface of circulating red blood cells can cause autoimmune hemolytic anemia. This most often occurs in hematologic malignancies, such as chronic lymphocytic leukemia (CLL), multiple myeloma, and lymphoma.
9 lip 2024 · In DIIHA, the presence of bite cells, blister cells, or irregularly shaped RBCs (poikilocytosis) suggests oxidative hemolysis, while spherocytes or microspherocytes indicate immune hemolysis. Schistocytes, on the other hand, suggest a thrombotic microangiopathy such as disseminated intravascular coagulation.
15 sie 2022 · The process of red blood cell destruction — including premature red blood cell destruction — is called hemolysis. Having too few red blood cells because of hemolysis causes a condition called hemolytic anemia.
3 wrz 2002 · The hallmark of hemolysis is shortened red blood cell survival in the peripheral blood. Hemolysis results in anemia only when bone marrow cannot keep up with the rate of red cell destruction. Even though anemia is very commonly observed in most cancer patients, hemolytic anemias are rather rare.
9 lip 2023 · Nucleated red blood cells (NRBCs) are premature erythrocyte precursors that reside in the bone marrow of humans of all ages as an element of erythropoiesis. They rarely present in healthy adults’ circulatory systems but can be found circulating in fetuses and neonates.
